Pediatrix Medical Group, Inc. (NYSE:MD) Shares Sold by Ameriprise Financial Inc.

Ameriprise Financial Inc. cut its holdings in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 21.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 264,742 shares of the company's stock after selling 72,243 shares during the period. Ameriprise Financial Inc. owned approximately 0.31% of Pediatrix Medical Group worth $3,473,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently made changes to their positions in MD. Pacer Advisors Inc. acquired a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at about $35,492,000. American Century Companies Inc. increased its holdings in Pediatrix Medical Group by 628.2% in the fourth quarter. American Century Companies Inc. now owns 1,739,323 shares of the company's stock worth $22,820,000 after purchasing an additional 1,500,485 shares in the last quarter. Oberweis Asset Management Inc. acquired a new position in shares of Pediatrix Medical Group during the 4th quarter valued at $6,122,000. Renaissance Technologies LLC boosted its position in shares of Pediatrix Medical Group by 117.4% during the 4th quarter. Renaissance Technologies LLC now owns 838,800 shares of the company's stock worth $11,005,000 after purchasing an additional 453,000 shares in the last quarter. Finally, Boston Partners grew its stake in Pediatrix Medical Group by 25.2% in the fourth quarter. Boston Partners now owns 1,956,353 shares of the company's stock valued at $25,922,000 after acquiring an additional 393,600 shares during the period. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

Shares of MD traded up $0.49 during trading hours on Thursday, hitting $14.21. The stock had a trading volume of 1,554,415 shares, compared to its average volume of 867,027. Pediatrix Medical Group, Inc. has a 12 month low of $6.62 and a 12 month high of $17.67. The firm has a market capitalization of $1.22 billion, a PE ratio of -11.84, a PEG ratio of 1.74 and a beta of 1.26. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock has a fifty day moving average price of $13.73 and a 200 day moving average price of $14.05.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, topping analysts' consensus estimates of $0.25 by $0.08. The firm had revenue of $458.36 million during the quarter, compared to analyst estimates of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. Pediatrix Medical Group's revenue for the quarter was down 7.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.20 earnings per share. Analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. UBS Group dropped their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. Truist Financial lowered their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating on the stock in a report on Friday, April 11th. Finally, Macquarie raised their price objective on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.